Collections
Maryland Code
Health—General
Title 21
2c
Prescription Drug Affordability Board
State of Maryland
Learn More
Log In
Sign Up
21-2C-01
Definitions
21-2C-02
Establishment; Purpose
21-2C-03
Membership
21-2C-04
Prescription Drug Affordability Stakeholder Council
21-2C-05
Disclosure of Conflict of Interest
21-2C-06
Acceptance of Gifts or Donations
21-2C-07
Study of Aspects of Pharmaceutical Distribution and Payment; Report
21-2C-08
Identifying Prescription Drug Products that Create Affordability Challenges for State Health Care System and Patients
21-2C-09
Cost Review of Prescription Drug Products Identified in § 21–2c–08
21-2C-10
Trade Secrets; Confidential and Proprietary Information
21-2C-11
Annual Fee; Prescription Drug Affordability Fund
21-2C-12
Enforcement of Subtitle
21-2C-13
Process for Setting Upper Payment Limits for Prescription Drug Products that Lead to Affordability Challenges
21-2C-14
Upper Payment Limits
21-2C-15
Appeals
21-2C-16
Upper Payment Limits for Purchases and Payor Reimbursements of Prescription Drug Products that Have Led or Will Lead to Affordability Challenges